论文部分内容阅读
心脑健是由浙江医科大学附属第二医院与玉环制药厂共同研制成功的降低纤维蛋白原的有效药物。在浙江省卫生厅和浙江省医药总公司主持下,于1983年12月21至22日在杭州召开了鉴定会。心脑健是由茶叶中提取而得的有效物质。国内经动物实验早已发现,茶叶有防治家兔实验性动脉粥样硬化的作用,其主要有效物质心脑健经动物实验与临床研究,发现具有抗凝、促进纤维蛋白溶解、防止血小板粘附以及防止家兔实验性动脉粥样硬化等作用。临床试用于214例伴有高纤维蛋白原症的单纯高脂血症、高血压症、冠心病等症,结果表明,心脑健有明显的降低纤维蛋白原的作用。适用于具有高凝状态的心血管疾病,有利于防治动脉粥样硬化。
Xinnaojian is an effective drug for reducing fibrinogen that was jointly developed by the Second Affiliated Hospital of Zhejiang Medical University and Yuhuan Pharmaceutical Factory. Under the auspices of the Zhejiang Provincial Health Department and the Zhejiang Provincial Pharmaceutical Corporation, an appraisal meeting was held in Hangzhou from December 21 to 22, 1983. Xinjianjian is an effective substance extracted from tea leaves. Domestic animal experiments have long found that tea has a role in the prevention and treatment of experimental atherosclerosis in rabbits. The main effective substances of the heart and brain by animal experiments and clinical studies have found anticoagulation, promote fibrinolysis, prevent platelet adhesion and Prevent experimental atherosclerosis and other effects in rabbits. Clinical trials in 214 patients with hyperfibrinogenemia, hyperlipidemia, hypertension, and coronary heart disease were performed. The results showed that the heart and brain have obvious effects on reducing fibrinogen. Applicable to cardiovascular disease with hypercoagulable state, which is conducive to prevention and treatment of atherosclerosis.